Clinical Trial Update: Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

View source ↗

Summary

Amgen-sponsored DMARD intervention and utilization trial for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Status: COMPLETED